Emerging Therapies for Ulcerative Colitis–Induced Pain

Newer drugs are more targeted than standard agents, but their incorporation into treatment regimens is challenging because of the risk of cardiovascular and infectious adverse events.

Antiphospholipid Syndrome and Its Management

Addressing this autoimmune disorder characterized by thrombosis or pregnancy morbidity coupled with persistent antiphospholipid antibodies involves identifying and mitigating thrombosis risk factors.

Drug-Resistant Fungal Infections on the Rise

To address this growing concern, researchers suggest adopting measures including patient education, routine diagnostic testing, and testing of antifungal susceptibility.

Combating Sepsis

This serious infection, which results from bacteria in the blood or other tissues, is the leading cause of death among adults in the ICU.

HEPLISAV-B

Take Quiz

Continuing Education

$7.95 Per CE Exam or $69 for 12 Lessons

Quick Poll

Does Your Pharmacy Have Enough COVID-19 Testing Supplies?